Aprogen Medicines Inc. (007460.KS) KSC

Currency In KRW

AD

Valuation

Market Cap229.48B
Enterprise Value372.19B
P/E Ratio-0.07
PEG Ratio-0.01
Price/Sales Ratio0.02
Price/Book Ratio0.72
Enterprise/Revenue1.05
Enterprise/EBITDA-1.21

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0.6
Operating Margin-0.72
AD

Management Effectiveness

Return On Assets-0.12
Return On Equity-0.64

Income Statement

Revenue117.97B
Revenue/Share6,433.57
Gross Profit33.24B
EBITDA-113.95B
Net Income-69.48B
Diluted EPS-52,533.75

Balance Sheet

Total Cash43.16B
Total Cash/Share1,999.21
Total Debt181.45B
Total Debt/Equity3
Current Ratio0.83
Book Value Per Share19,199.49

Price History

52-Week Change-98.78
52-Week High14,062.97
52-Week Low1,961
Moving Average 50 Days2,332.5
Moving Average 200 Days5,570.61

Statistics

Average Volume311,968
Shares Outstanding1.4M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0
Last Split Factor1:15
Last Split DateMay 08, 2026
AD